Unknown

Dataset Information

Recent advances and updated highlights in breast cancer pathologic diagnosis: a narrative review.


ABSTRACT:

Background and objective

With the rapid development of breast cancer treatment, breast cancer pathologic diagnosis has faced many requirements and challenges. This article reviews and summarizes important results that will change the clinical practice of breast cancer in 2023 and 2024.

Methods

As of April 2024, a comprehensive literature search, compilation, and analysis were conducted across PubMed, Baidu Scholar, ClinicalTrials.gov, and relevant academic conferences.

Key content and findings

This article focused on invasive lobular carcinoma (ILC), phyllodes tumors, new advances in immunohistochemical (IHC) indexes, updated advances in neoadjuvant therapy for breast cancer, and advances in the study of human epidermal growth factor receptor 2 (HER2)-low breast cance

SUBMITTER: Liu Y 

PROVIDER: S-EPMC11836733 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature